XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows used in operating activities:    
Net (loss) income $ (853) $ 1,194
Adjustments to reconcile net (loss) income to cash used in operating activities:    
Gain from sale of OSP (Note 3) (957) 0
Depreciation and amortization 425 375
Deferred income taxes (221) (59)
Non-cash interest 1,264 640
Long lived asset impairment 352 0
Stock-based compensation 1,430 630
Amortization of debt discount and financing costs 719 747
Other non-cash items affecting earnings (80) 238
Changes in operating assets and liabilities, excluding the effects of asset sales [1] (3,423) (6,589)
Net cash used in operating activities (1,344) (2,824)
Cash flows provided by (used in) investing activities:    
Capital expenditures (16) (163)
Proceeds from sale of OSP, net of fees 957 0
Net cash provided by (used in) investing activities 941 (163)
Cash flows (used in) provided by financing activities:    
Borrowings on revolving credit facility 4,326 2,000
Repayments of revolving credit facility (10,237) 0
Repayments of long-term debt (263) (162)
Debt refinancing fees (298) (152)
Taxes paid for shares withheld (23) (6)
Net cash (used in) provided by financing activities (6,495) 1,680
Effect of exchange rate changes on cash and cash equivalents 27 (42)
Decrease in cash, cash equivalents, and restricted cash (6,871) (1,349)
Cash, cash equivalents and restricted cash:    
Beginning of period 29,312 21,396
End of period $ 22,441 $ 20,047
[1] Changes in operating assets and liabilities exclude assets and liabilities sold.